LatAm & Caribbean / Importance of Reliance to Support Strengthening Regulatory Systems
Writing in the April edition of DIA’s Global Forum magazine, Maria Cristina Mota Pina of Abbvie on behalf of…
Top Stories
UK / Fastest Growing Private Pharmacos; GSK Shake-Up; Brexit Uncertainties; COVID-19 Reinfection Trial
The latest UK pharma news, including how new investment in GSK stands to reshape the country’s iconic pharma giant; CDMO Sterling’s latest acquisition; and calls for a national registry to…
Personalised Medicine / Miro Venturi - CEO, Sintetica
Dr Miro Venturi of Swiss injectable anaesthetics and analgesics specialist Sintetica outlines his career journey,…
APAC / The Challenges of Regulatory Convergence in Medtech
Regulatory harmonisation for medical devices between countries in Asia-Pacific has long been a challenging issue,…
Data / BC Platforms CEO on Data's Transformational Impact for Healthcare Systems & Life Sciences R&D
CEO Tero Silvola introduces BC Platforms’ powerful data and technology platform for personalized medicine and…
Switzerland / MSD AVP on New Zurich R&D Investment
In February 2020, US giant MSD announced the launch of a new site in Zurich specialising in R&D, data…
China / Antitrust Threat to Pharma; June BioNTech Vaccine Approval; EpimAb IPO; CanSino Inhaled Vaccine Trials
The latest China pharma news, including the upcoming first domestic approval for a foreign COVID-19 vaccine in…
In Conversation
Michael Altorfer – CEO, Swiss Biotech Association
Michael Altorfer, CEO of the Swiss Biotech Association, a membership organisation representing the interests of the Swiss biotech industry, discusses the evolution of the biotech sector in Switzerland, how the country’s ecosystem has helped foster success stories like Actelion, and the multilateral work being done to improve intellectual property protection in China and the rest of the world. Switzerland…
Latest Reports
Focus on Europe
Can Europe’s Beating Cancer Plan Make it an Innovation…
The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating…
Valneva: A COVID-19 Vaccine Success Story for France?
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed…
Switzerland: A Sea Change in the Biotech Start-up Ecosystem?
In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine…
UK Pharma News: Fastest Growing Private Pharmacos; GSK…
The latest UK pharma news, including how new investment in GSK stands to reshape…
Read more: Europe >>
Focus on Vaccines
UK Pharma News: Fastest Growing Private Pharmacos; GSK…
The latest UK pharma news, including how new investment in GSK stands to reshape…
China Pharma News: Antitrust Threat to Pharma; June BioNTech…
The latest China pharma news, including the upcoming first domestic approval for…
Russia Pharma News: Biocad Ramps up Sputnik V Manufacturing;…
The latest news from Russian pharma, including Biocad’s ramping up of Sputnik…
Italy Pharma News: Mandatory COVID-19 Vaccines for…
The latest from Italian pharma, including the government’s decision to make…
Read more: Vaccines >>
Focus on USA
5 US Rare Disease Start-Ups to Watch
Following on from our profile on five of the most promising clinical-stage…
NORD Chief Strategy Officer on Health Equity’s Vital…
With Rare Disease Day coming up on February 28th, one of the leading…
USA: 2 Things the Biden Administration can do Now to Lower…
PhRMA’s Stephen J. Ubl outlines two ways in which the new US presidency can…
Novavax: From No-Hoper to COVID-19 Vaccine Saviour?
From almost being de-listed by the NASDAQ stock index in 2018 due to poor…
Read more: USA >>
Focus on Singapore
Medtech’s Post-COVID Paradigm in APAC
At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech…
The Challenges of Regulatory Convergence in APAC Medtech
Regulatory harmonisation for medical devices between countries in Asia-Pacific…
HSA: APAC’s Regulatory Gold Standard
As the most important pharma hub in its region, and one of the most important…
Singapore Pharma Industry Snapshot 2020
Singapore is home to a wide range of biopharmaceutical company headquarters,…
Read more: Singapore >>
Focus on China
Boehringer Ingelheim’s Stroke Rehab Centre Success…
In March 2018, German pharma player Boehringer Ingelheim (BI)'s Consanas…
Top 10 Chinese Pharma Companies 2020
The Top 10 Chinese pharma companies for 2020 ranked by overall revenues. Taken…
China: Yangtze River Pharmaceutical Group (YRPG) in Profile
One of the largest domestic pharma companies in China (ranking number one from…
Public Insurance Coverage for Rare Disease Patients in…
Kevin Rufang Huang, president and founder of the Chinese Organization for Rare…
Read more: China >>
Focus on Switzerland
Swiss Pharma: Staying the Course
This article forms part of Healthcare & Life Sciences Review: Switzerland…
Building a Health Data Ecosystem in Switzerland
Although Switzerland is ahead of many of its competitors in Europe on levels of…
ISREC’s Susan Gasser: A “Hard-Nosed” Approach to…
After 15 years as director at the Friedrich Miescher Institute for Biomedical…
Ichnos CEO on Glenmark Legacy, Biotech Transformation &…
After an illustrious career in oncology R&D, contributing greatly to the…
Read more: Switzerland >>
Focus on MEA
5 Saudi Arabian Pharma Companies to Know
Following on from our list of the overall top 10 companies in the Saudi Arabian…
MEA: Iran looks to Cuba for COVID-19 Vaccine; Israel Leads…
The latest COVID-19 vaccine news from the Middle East & Africa (MEA) region,…
MEA Roundup: Turkey’s Pharma Debt; Saudi Market Rise; UAE…
A roundup of the latest from the Middle East & Africa region, including…
MEA: Pfizer’s Saudi Transformation; Urgent Call for Arab…
The latest news from Middle East & North African pharma, including…